BLU-667 Archives - Medical Conferences

Novel RET inhibitor BLU-667 offers promise for RET+ advanced NSCLC

Presented By

Dr Justin F. Gainor, Massachusetts General Hospital, USA

Trial

Phase 1, ARROW

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 19:23

Osimertinib and RET inhibitor BLU-667 in an EGFR-mutant patient with acquired RET rearrangement

Conference

WCLC 2018

Type

Peer-reviewed article

21 November 2018 23:51

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com